{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:05:49Z","timestamp":1792267549484,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of nanocarriers in drug delivery is a breakeven research and has received a clarion call in biomedicine globally. Herein, two newly nano-biomaterials: MCM-41 encapsulated quinine (MCM-41\u2009\u2283\u2009QN) (<jats:bold>1<\/jats:bold>) and 3-phenylpropyl silane functionalized MCM-41 loaded QN (pMCM-41\u2009\u2283\u2009QN) (<jats:bold>2<\/jats:bold>) were synthesized and well characterized. <jats:bold>1<\/jats:bold> and <jats:bold>2<\/jats:bold> along with our two already reported nano-antimalarial drugs (MCM-41\u2009\u2283\u2009ATS) (<jats:bold>3<\/jats:bold>) and 3-aminopropyl silane functionalized MCM-41 contained ATS (aMCM-41\u2009\u2283\u2009ATS) (<jats:bold>4<\/jats:bold>) were screened <jats:italic>in vitro<\/jats:italic> for their activity against <jats:italic>P. falciparium<\/jats:italic> W2 strain, cytotoxicity against BGM cells and <jats:italic>in vivo<\/jats:italic> for their activity against <jats:italic>Plasmodium bergheiNK65<\/jats:italic>. <jats:bold>1<\/jats:bold> has the highest antimalarial activity <jats:italic>in vivo<\/jats:italic> against <jats:italic>P. berghei<\/jats:italic> NK65, (ED<jats:sub>50<\/jats:sub>:\u2009&lt;\u20090.0625\u2009mg\/kg body weight) and higher mean survival time compared to the other nano biomaterials or unencapsulated drugs at doses higher than 0.0625\u2009mg\/kg body weight. This encapsulation strategy of MCM-41\u2009\u2283\u2009QN (<jats:bold>1<\/jats:bold>) stands very useful and effective in delivering the drug to the target cells compared to other delivery systems and therefore, this encapsulated drug may be considered for rational drug design.<\/jats:p>","DOI":"10.1038\/s41598-018-21351-8","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T11:14:23Z","timestamp":1518174863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance"],"prefix":"10.1038","volume":"8","author":[{"given":"Saliu Alao","family":"Amolegbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Oluwatope","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusegun George","family":"Ademowo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Abidemi","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Ayoola","family":"Obaleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoniana Ursine","family":"Krettli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8392-2382","authenticated-orcid":false,"given":"Shinya","family":"Hayami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"21351_CR1","unstructured":"World Health Organization (WHO) Global Malaria Programme, World Malaria Report (2015). http:\/\/apps.who.int\/iris\/bitstream\/10665\/200018\/1\/9789241565158_eng.pdf?ua=1d accessed February 20 (2017)."},{"key":"21351_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","volume":"12","author":"T Vasconcelos","year":"2007","unstructured":"Vasconcelos, T., Sarmento, B. & Costa, P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today 12, 1068\u20131075 (2007).","journal-title":"Drug Discovery Today"},{"key":"21351_CR3","unstructured":"Kwon, I. K., Jeong, S. H., Kang, E. & Park, K. Nanoparticle drug delivery Systems for Cancer therapy. Cancer Nanotechnol. 333\u2013344 (2007)."},{"key":"21351_CR4","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1021\/ja807798g","volume":"131","author":"DP Ferris","year":"2009","unstructured":"Ferris, D. P. et al. Light \u2013 operated mechanized nanoparticles. J. Am Chem. Soc. 131, 1686\u20131688 (2009).","journal-title":"J. Am Chem. Soc."},{"key":"21351_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature03342","volume":"434","author":"RW Snow","year":"2005","unstructured":"Snow, R. W., Guerra, C. A., Noor, A. N., Myint, H. Y. & Hay, S. I. The Global Distribution of Clinical Episodes of Plasmodium Falciparium Malaria. Nature. 434, 214\u2013217 (2005).","journal-title":"Nature."},{"key":"21351_CR6","unstructured":"Simon I. H. et al. Estimating the Global Clinical Byrden of Plasmodium falciparum. Malaria, Plos Med 7 (2007)."},{"key":"21351_CR7","first-page":"509","volume":"3","author":"DA Fidock","year":"2004","unstructured":"Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R. & Nwaka, S. Antimalarial Drug discovery: Efficacy models for compound screening. Nature reviews 3, 509\u2013520 (2004).","journal-title":"Nature reviews"},{"issue":"3","key":"21351_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/0960327111424298","volume":"1","author":"JO Adebayo","year":"2012","unstructured":"Adebayo, J. O., Santana, A. E. G. & Krettli, A. U. Evaluation of the Antiplasmodial and Cytotoxicity potentials of husk fibre extracts from Cocos nucifera, a medicinal plant used in Nigeria to treat human malaria. Human and Experimental Toxicology3 1(3), 244\u2013249 (2012).","journal-title":"Human and Experimental Toxicology3"},{"key":"21351_CR9","first-page":"38","volume":"24","author":"EA Balogun","year":"2012","unstructured":"Balogun, E. A., Akinloye, O. A., Lasisi, A. A. & Adeyi, O. E. Biochemical and histological changes associated with treatment of malaria and diabetes mellitus in mice with extracts of Marmodiaca charantia. Biokemstri 24, 38\u201347 (2012).","journal-title":"Biokemstri"},{"issue":"6","key":"21351_CR10","first-page":"431","volume":"2","author":"P Rathee","year":"2015","unstructured":"Rathee, P., Dalal, A., Kumar, A. & Ruhil, M. Nanotechnology A potential tool in malarial chemotherapy-review. International Journal of Multidisciplinary Research and Development 2(6), 431\u2013434 (2015).","journal-title":"International Journal of Multidisciplinary Research and Development"},{"key":"21351_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"NS Santos-Magalhaes","year":"2010","unstructured":"Santos-Magalhaes, N. S. & Mosqueira, V. C. F. Nanotechnology applied to the treatment of malaria. Advanced drug delivery reviews 62, 560\u2013575 (2010).","journal-title":"Advanced drug delivery reviews"},{"key":"21351_CR12","unstructured":"Vaidya, A. B. et al. Pyrazoleamide compounds are potent antimalarials that target Na+\u2009homeostasis in intraerythrocytic Plasodium falciparum, Nature communication, DOI (2014)."},{"key":"21351_CR13","unstructured":"Lasisi, A. A., Olayiwola, M. A., Balogun, S. A., Akinloye, O. A. & Ojo, D. A. Phytochemical composition, cytotoxicity and in vitro antiplasmodial activity of fractions from Alafia barteriolive (Hook F. Icon) -Apocynaceae. Journal of Saudi Chemical Society (2012)."},{"key":"21351_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00775-016-1421-4","volume":"22","author":"SA Amolegbe","year":"2017","unstructured":"Amolegbe, S. A. et al. Some non toxic metal-based drugs for selected prevalent tropical pathogenic diseases. J. Biol Inorg Chem 22, 1\u201318 (2017).","journal-title":"J. Biol Inorg Chem"},{"issue":"18","key":"21351_CR15","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1073\/pnas.85.18.6949","volume":"85","author":"A Gabizon","year":"1988","unstructured":"Gabizon, A. & Papahadjopoulos, D. Liposomes formulations with prolonged circulation time in blood and enhanced uptake by tumors. P. Natl Acad Sci USA 85(18), 6949\u20136949 (1988).","journal-title":"P. Natl Acad Sci USA"},{"issue":"1","key":"21351_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6700(97)00025-7","volume":"23","author":"OA Mathews","year":"1998","unstructured":"Mathews, O. A., Shipway, A. N. & Stoddart, J. F. Dendrimers-branching out from curiosities into new technologies. Prog Polym Sci. 23(1), 1\u201356 (1998).","journal-title":"Prog Polym Sci."},{"key":"21351_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","volume":"103","author":"ES Lee","year":"2005","unstructured":"Lee, E. S., Na, K. & Bae, Y. H. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control Release 103, 405\u2013418 (2005).","journal-title":"J. Control Release"},{"key":"21351_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jconrel.2011.04.006","volume":"152","author":"H Zhang","year":"2011","unstructured":"Zhang, H. et al. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen. Journal of Controlled Release 152, e1\u2013e132 (2011).","journal-title":"Journal of Controlled Release"},{"key":"21351_CR19","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.1021\/ja0619049","volume":"128","author":"S Yang","year":"2006","unstructured":"Yang, S. et al. On the origin of helical mesostructures. J. Am. Chem. Soc. 128, 10460\u201310466 (2006).","journal-title":"J. Am. Chem. Soc."},{"issue":"27","key":"21351_CR20","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1021\/ja00053a020","volume":"114","author":"JS Beck","year":"1992","unstructured":"Beck, J. S. et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 114(27), 10834\u201310843 (1992).","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"21351_CR21","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/ja0645943","volume":"128","author":"I Slowing","year":"2006","unstructured":"Slowing, I., Trewyn, B. G. & Lin, V. S. Effect of surface function of MCM-41 type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 128(46), 14792\u201314793 (2006).","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"21351_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/(SICI)1521-4095(200003)12:6<430::AID-ADMA430>3.0.CO;2-3","volume":"12","author":"J Francisco de","year":"2000","unstructured":"Francisco de, J. & Edwardo, R.-H. Selective Functionalization of Mesoporous Silica. Adv.Mater 12(6), 430\u2013432 (2000).","journal-title":"Adv.Mater"},{"key":"21351_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2013.12.032","volume":"177","author":"P Urban","year":"2014","unstructured":"Urban, P. et al. Use of poly (amidoamine) drug conjugates for the delivery of antimalarials to plasmodium. Journal of Controlled Release 177, 84\u201395 (2014).","journal-title":"Journal of Controlled Release"},{"key":"21351_CR24","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1016\/j.biomaterials.2014.05.061","volume":"35","author":"J Movellan","year":"2014","unstructured":"Movellan, J. et al. Amphiphilic dendritic derivatives as nanocarriers for the targeted deloivery of antimalarial drugs. Biomaterials 35, 7940\u20137950 (2014).","journal-title":"Biomaterials"},{"key":"21351_CR25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4269\/ajtmh.2007.77.181","volume":"77","author":"F Nosten","year":"2007","unstructured":"Nosten, F. & White, N. J. Artemisinin-based combination treatment of falciparum malarial. Am. J. Trop. Med Hyg. 77, 180\u2013192 (2007).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"21351_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.02.024","volume":"34","author":"SH Haas","year":"2009","unstructured":"Haas, S. H., Bettoni, C. C., Oliveira, L. K., Guterres, S. I. S. & Costa, T. D. Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium. bergheiin viv., Int. J. Antimicrob. Agents 34, 156\u2013161 (2009).","journal-title":"bergheiin viv., Int. J. Antimicrob. Agents"},{"key":"21351_CR27","first-page":"187","volume":"1331","author":"PR Culli","year":"1997","unstructured":"Culli, P. R. et al. Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles, BBA-Rev. Biomembranes 1331, 187\u2013211 (1997).","journal-title":"Biomembranes"},{"key":"21351_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0731-7085(02)00678-7","volume":"31","author":"M Gabriels","year":"2003","unstructured":"Gabriels, M. & Plaizier-Vercammen, J. Physical and Chemical evaluation of liposomes, containing artesunate. J. Pharm. Biomed. Anal. 31, 655\u2013667 (2003).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"21351_CR29","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1039\/C5TB02200B","volume":"4","author":"SA Amolegbe","year":"2016","unstructured":"Amolegbe, S. A. et al. Synthesis of mesoporous materials as nano-carriers for an antimalarial drug. J. Mater. Chem., B 4, 1040\u20131043 (2016).","journal-title":"J. Mater. Chem., B"},{"key":"21351_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1039\/C3RA44257H","volume":"4","author":"S Jambhrunkar","year":"2014","unstructured":"Jambhrunkar, S., Karmakar, S., Popat, A., Yu, M. & Yu, C. Mesoporous silica nanoparticles enhance the cytoxicity of curmin. RSC Advances 4, 709\u2013712 (2014).","journal-title":"RSC Advances"},{"key":"21351_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/cm9704600","volume":"10","author":"MT Anderson","year":"1998","unstructured":"Anderson, M. T., Martin, J. E., Odinek, J. G. & Newcorner, P. P. Surfactant-Templated Silica Mesophases Formed inWater: Cosolvent Mixtures. Chem. Mater 10, 311\u2013321 (1998).","journal-title":"Chem. Mater"},{"key":"21351_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cclet.2013.11.002","volume":"25","author":"Q Zhang","year":"2014","unstructured":"Zhang, Q., Ye, Z., Wang, S.-T. & Yin, J. Facile one-pot synthesis of PEGylated monodisperse mesoporous silica nanoparticles with controllable particles sizes. Chinese Chemical letters 25, 257\u2013260 (2014).","journal-title":"Chinese Chemical letters"},{"key":"21351_CR33","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/j.biomaterials.2010.01.015","volume":"31","author":"Q He","year":"2010","unstructured":"He, Q., Shi, J., Chen, F., Zhu, M. & Zhang, L. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials 31, 3335\u20133346 (2010).","journal-title":"Biomaterials"},{"key":"21351_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.micromeso.2010.11.013","volume":"141","author":"Y Zhu","year":"2011","unstructured":"Zhu, Y., Fang, Y., Borchardt, L. & Kaskel, S. PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Microporous and Mesoporous Materials 141, 199\u2013206 (2011).","journal-title":"Microporous and Mesoporous Materials"},{"key":"21351_CR35","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1016\/j.biomaterials.2014.01.013","volume":"35","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Biofunctionalized polymer-lipid supported mesoporous silica nanopartciles for release of chemotherapeutics in multidrug resistant cancer cells. Biomaterials 35, 3650\u20133665 (2014).","journal-title":"Biomaterials"},{"key":"21351_CR36","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.biomaterials.2012.12.040","volume":"34","author":"L Pan","year":"2013","unstructured":"Pan, L., Liu, J., He, Q., Wang, L. & Shi, J. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials 34, 2719\u20132730 (2013).","journal-title":"Biomaterials"},{"key":"21351_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp200287c","volume":"9","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Mesoporous Silica nanoparticles for Increasing the Oral Bioavailability and Permeation of Poorly Water SolubleDrugs. Mol. Pharmaceutic 9, 505\u2013513 (2012).","journal-title":"Mol. Pharmaceutic"},{"key":"21351_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ilar.38.1.41","volume":"38","author":"JD Clark","year":"1997","unstructured":"Clark, J. D., Gebhart, G. F., Gouder, J. C., Keeling, M. E. & Kohn, D. F. The 1996 Guide for the care and use of laboratory animals. ILAR Journal 38, 41\u201348 (1997).","journal-title":"ILAR Journal"},{"key":"21351_CR39","unstructured":"Garber, J. C. et al. Guide for the care and use ofLaboratory animals. Eight edition, The National Academic press, 500 fifth street Washington DC 20055, (800) 624\u20136242 (2011)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21351-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21351-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21351-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:26:47Z","timestamp":1671589607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21351-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21351"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21351-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"6 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3078"}}